Table 2 Patients characteristics in individual groups

Age at initial visit (year)

0-10 (Median 2.8)

0-44 (Median 28)

< 0.00005

****

Gender (Male/Female)

28/24

5/52

< 0.00005

0.001

ALT level (IU/L) at initial visit

10-725 (Median 80.5)

7-767 (Median 23)

< 0.00005

0.489

Duration of follow-up period (year)

1-21 (Median 10.0)*

1-25 (Median, 6.0)

0.6218

0.013

Age at HBe seroconversion

1-10 (Median 6.5)

21-34 (Median 25)**

Not done

Not done

Serum HBV DNA level at last visit (log copies/mL)

2.5-8.7 (Median 4.8)***

3.0-9.0 (Median 8.5)

< 0.00005

0.003

Transmission route

Mother-to-child

43

37

Mother-to-child

Household contacts

5

4

v.s. Non Mother-to-child

Blood transfusion

1

0

0.036

0.016

Unknown

3

16

HBV Genotype

A

0

1

Genotype C

B

7

10

v.s. Non genotype C

C

44

45

0.445

0.221

D

1

1